Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Fudan University
University of Washington
OHSU Knight Cancer Institute
M.D. Anderson Cancer Center
Eli Lilly and Company
University Health Network, Toronto
Eli Lilly and Company
Jules Bordet Institute
OHSU Knight Cancer Institute
Abramson Cancer Center at Penn Medicine
Eli Lilly and Company
Eli Lilly and Company
Eli Lilly and Company